Eighteen-year-old Arjun Deshpande has been eagerly waiting for his class 12 results while the Covid19 lockdown continues in Mumbai. He loves football and reading. But he is not a regular teenager.
He is the founder of a start-up that employs 55 people and has managed to catch the attention of Tata Group patriarch Ratan Tata. The industrialist has now invested in his pharmaceutical business venture Generic Aadhaar to provide affordable medicines to the masses. Deshpande, who completed his schooling from DAV Public School, Thane, was a globe trotter from a young age.
Generic Aadhaar aims at providing affordable and quality medicines to every Indian, by aggregating the medical stores under one umbrella. The company procures medicines directly from WHO GMP approved facilities and makes these medicines accessible to everyone at Generic Aadhaar aggregated stores across India. This has helped the medical store owners who have to compete with online pharmacies and big medical malls. Generic Aadhaar is taking single medical stores under one umbrella, have built online + offline ecosystem. Generic Aadhaar is B2B2C business model
Ambitious and dedicated, Arjun Deshpande founded Generic Aadhaar when he was just 16 years old. Generic Aadhaar revolutionized the way Indian Pharmaceutical Industry works. It is the first company to support individual medical store owners by helping them gain their huge clientele back.
Arjun Deshpande, one of the youngest entrepreneurs of India, seems to be inspired by his mother who is into an international pharma business. He used to travel to USA, Vietnam, China and Dubai in his school holidays and it was during the meetings with various importers, distributors and MOH Authorities that he learnt that people in these countries had access to affordable medicines. He asked his mother why medicines are sold in India at comparatively higher prices. He further learnt that most generic medicines in India are promoted as branded medicines which raise its cost.
After exhaustive research and analysis of medicines, Arjun found that most generic and branded medicines have the same compositions. They are promoted by marketing gimmicks and therefore, many people can’t even afford these medicines. At this point, Arjun vowed to make quality medicines affordable for every Indian. This led to the foundation of Generic Aadhaar, a dream project that is making affordable healthcare a reality in India.
He has been Awarded *Youngest Student Entrepreneur of the Year 2019* by *Entrepreneur India 2019 *held on 18th July at JW Marriott New Delhi. Arjun made innovative revolution, in typical Pharma Industry for betterment of common man of India.
Generic Aadhaar® is an Register Trademark of Swasthya Lifescience Pvt.Ltd.Generic Aadhaar® having its, multiple outlets shortly expanding our brand Generic Aadhaar® in every city of India to Provide affordable healthcare to every Indian. It provides biggest portfolio of Branded, Generic, Homeopathy, Ayurveda medicines from government approved quality manufacturing facilities.
In accordance with the Prime Minister’s vision, Generic Aadhaar® is aggregators of pharmacy chain of medicines to support ‘Make in India & Start Up India’ drive with quality medicines at true affordable prices to every Indian quality with affordability
Generic Aadhaar® manufacture medicines from government approved manufacturing sites and directly sell to our stores to cut off unwanted cost of brand promotion at the same time ensuring best quality.
Arjun Deshpande, wish single medical store to grow in market. In today’s Global market of pharmaceutical small medical stores are facing huge competition. You should not be option for customer, but you should be the first choice of customer and for this Generic Aadhaar® is here to support you and provide our customers affordable quality Branded and Generic Medicines.
On Thursday (May 07), Ratan Tata has picked up stakes in a Mumbai based pharmacy retail chain called Generic Aadhar. Arjun Deshpande, Founder and CEO said that “When Ratan Tata came to know about the business plan, he decided to be a part of this mission in a personal capacity and help Generic Aadhaar to reach every Indian.”
The startup claims annual revenue of Rs 6 crore and is targeting Rs 150-200 crore in the next three years.
Currently, Generic Aadhaar supplies diabetes and hypertension medicines but will soon start offering cancer drugs at rates much lower than the market price, it claims. It has a tie-up with four WHO-GMP certified manufacturers in Palghar, Ahmedabad, Pondicherry, and Nagpur.
आपको यह Motivational Story कैसी लगी? आप अपनी प्रतिक्रिया नीचे कमेंट बॉक्स में दे और इस पोस्ट को ज्यादा से ज्यादा Share करें।
